feed,title,long_url,short_url
Investors,Fibrogen Plunges On Murky Safety Disclosure For Controversial Drug,https://www.investors.com/news/technology/fibrogen-stock-plummets-murky-disclosure-anemia-treatment/,https://j.mp/39QGtwS
